日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Case Report: A successful rechallenge with aumolertinib after osimertinib-induced severe interstitial lung disease

病例报告：奥希替尼诱发严重间质性肺疾病后，再次使用奥莫替尼治疗取得成功

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2026.1785616
Bao, Hejing; Deng, Caijiu; Luo, Xi; Su, Haoran; Bao, Hehong; Hu, Jiazhu; Cao, Xiaolong; Lin, Liping
发表日期：2026
文献求助 收藏

Case Report: Subacute cutaneous lupus erythematosus induced by the anti-PD-1 antibody camrelizumab combined with chemotherapy

病例报告：抗PD-1抗体卡瑞利珠单抗联合化疗诱发的亚急性皮肤红斑狼疮

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1539373
Bao, Hejing; Zhang, Jiani; Luo, Xi; Song, Xiaojing; Li, Juan; Mao, Nan; Chen, Fang; Bao, Hehong; Hu, Jiazhu; Cao, Xiaolong; Ma, Shudong; Lin, Liping
红斑狼疮
PD-1
免疫/内分泌
发表日期：2025
文献求助 收藏

Linoleic acid drives pulmonary lymphoepithelioma-like carcinoma progression via PPAR-α/TF axis.

亚油酸通过 PPAR-α/TF 轴驱动肺淋巴上皮瘤样癌的进展

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1640201
Bao Hejing, Zhang Jiani, Chen Zhuoyan, Wang Yuhuan, Wang Zhe, Chen Zhiting, Jiang Ting, Zhang Baishen, Zeng Wen, Bao Hehong, Ma Shudong
肿瘤
发表日期：2025
文献求助 收藏

Gut microbiota and pancreatic cancer risk, and the mediating role of immune cells and inflammatory cytokines: a Mendelian randomization study

肠道菌群与胰腺癌风险，以及免疫细胞和炎症细胞因子的介导作用：一项孟德尔随机化研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1408770
Chen, Zhiting; Wang, Zhe; Bao, Hejing; Ma, Shudong
肿瘤
炎症
肿瘤免疫
细胞生物学
炎症/感染
微生物学
肠道菌群
胰腺癌
免疫/内分泌
发表日期：2024
文献求助 收藏

Case Report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression

病例报告：安罗替尼联合信迪利单抗治疗RET融合和PD-L1表达阳性肺腺癌的疗效

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1448291
Bao, Hejing; Zhang, Jiani; Wang, Yuhuan; Chen, Zhiting; Luo, Xi; Li, Ting; Su, Haoran; Bao, Hehong; Cao, Xiaolong; Lin, Liping
PD-L1
肿瘤
肿瘤免疫
RET
发表日期：2024
文献求助 收藏

Immune cells mediated the causal relationship between the gut microbiota and lung cancer: a Mendelian randomization study

免疫细胞介导肠道菌群与肺癌之间的因果关系：一项孟德尔随机化研究

期刊:Frontiers in Microbiology
影响因子:4.5
doi:10.3389/fmicb.2024.1390722
Chen, Zhiting; Wang, Zhe; Ma, Hao; Bao, Hejing; Jiang, Ting; Yang, Ting; Ma, Shudong
细胞生物学
肿瘤
微生物学
免疫/内分泌
肿瘤免疫
肠道菌群
肺癌
发表日期：2024
文献求助 收藏

Radical chemoradiotherapy for superficial esophageal cancer complicated with liver cirrhosis

根治性放化疗治疗合并肝硬化的浅表性食管癌

期刊:PeerJ
影响因子:2.4
doi:10.7717/peerj.18065
Bao, Hejing; Bao, Hehong; Lin, Liping; Wang, Yuhuan; Zhang, Longbin; Zhang, Li; Zhang, Han; Liu, Lingxiang; Cao, Xiaolong
食管癌
肿瘤
肝硬化
肿瘤免疫
发表日期：2024
文献求助 收藏

Anti-angiogenic therapy for advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective multicenter study

抗血管生成疗法治疗晚期原发性肺淋巴上皮瘤样癌：一项回顾性多中心研究

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-022-03935-0
Bao, Hejing; Ma, Ling Zhen; Zhao, Chengzhu; Yu, Mengge; Zhang, Baishen; Zhang, Juan; Peng, Guibao; Lin, Xiaotong; Fang, Yinhua; Bao, Hehong; Ma, Shudong
肿瘤
血管生成
肿瘤免疫
发表日期：2023
文献求助 收藏

Alterations of lung microbiota in patients with non-small cell lung cancer

非小细胞肺癌患者肺部微生物群的改变

期刊:Bioengineered
影响因子:4.2
doi:10.1080/21655979.2022.2045843
Zeng, Wen; Zhao, ChengZhu; Yu, Mengge; Chen, Hailong; Pan, Yiyun; Wang, Yuhuan; Bao, Hejing; Ma, Hao; Ma, Shudong
肺癌
肿瘤
肿瘤免疫
微生物学
细胞生物学
发表日期：2022
文献求助 收藏

Immunosuppression and cardiovascular dysfunction in patients with severe versus mild coronavirus disease 2019: a case series

重症与轻症冠状病毒病患者的免疫抑制和心血管功能障碍：病例系列研究

期刊:Clinical & Translational Immunology
影响因子:3.8
doi:10.1002/cti2.1188
Bao, Hejing; Li, Gang; Fang, Yinhua; Lai, Qin; Bao, Hehong; Zheng, Yu; Hu, Yanjun
微生物学
免疫/内分泌
发表日期：2020
文献求助 收藏